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Introduction {#sec001}
============

Hematopoiesis is a process by which hematopoietic stem cells (HSCs) produce all the mature blood in an animal through a series of proliferating and differentiating divisions \[[@pcbi.1006489.ref001]\]. Maintenance of balanced hematopoietic output is critical for an organism's survival and determines its response to disease and clinical procedures such as bone marrow transplantation \[[@pcbi.1006489.ref002]--[@pcbi.1006489.ref005]\]. How the relatively small HSC population generates more than 10^11^ cells of multiple types daily over an organism's lifetime has yet to be fully understood. HSCs are defined primarily by their function but are often quiescent \[[@pcbi.1006489.ref006]\]. *In vivo*, it is hard to track the dynamics of individual HSCs, while HSCs *in vitro* do not typically proliferate or differentiate as efficiently. Therefore, the dynamics of HSCs can be inferred only from analyses of populations of progenitors and differentiated blood cells \[[@pcbi.1006489.ref007]\] and it is useful to investigate HSC dynamics through mathematical modeling and simulations \[[@pcbi.1006489.ref008]--[@pcbi.1006489.ref010]\].

While most studies model population-level HSC behavior \[[@pcbi.1006489.ref005], [@pcbi.1006489.ref011], [@pcbi.1006489.ref012]\], certain aspects of HSCs, such as individual-level heterogeneity in repopulation and differentiation dynamics, have to be studied on a single-cell or clonal level \[[@pcbi.1006489.ref013]\]. Single HSC transplant mouse data \[[@pcbi.1006489.ref014]\] and clonal tracking of HSCs \[[@pcbi.1006489.ref015], [@pcbi.1006489.ref016]\] in mice have shed some light on repopulation dynamics under homeostasis and after bone marrow transplantation \[[@pcbi.1006489.ref005], [@pcbi.1006489.ref017], [@pcbi.1006489.ref018]\]. However, murine studies usually involve only one or a few clones. How each individual HSC contributes to the blood production process over long times in much larger human and non-human primates is less clear and more difficult to study. Also, unlike in mice, there is no way to isolate and mark HSC populations in human \[[@pcbi.1006489.ref019]\].

Recently, results of a long-term clonal tracking of hematopoiesis in normal-state rhesus macaques has been made available \[[@pcbi.1006489.ref013], [@pcbi.1006489.ref020]\]. The experiment extracted and uniquely "labelled" hematopoietic stem and progenitor cells (HSPCs) from four rhesus macaques with viral tags that also carry an enhanced green fluorescent protein gene. After autologous transplantation, if any of the tagged HSPCs divide and differentiate, its progeny will inherit their unique tags and ultimately appear in the peripheral blood. Blood samples were drawn every few months over 4 − 14 years (depending on the animal) and the sampled cells were counted and sequenced. Of the ∼10^6^ − 10^7^ unique HSPC tags transplanted, ∼10^2^ − 10^3^ clones were detected in the sampled peripheral blood. In the original paper describing the clonal tracking experiment, Kim *et al*. \[[@pcbi.1006489.ref013]\] observed "A small fraction (4 − 10%) of tagged clones predominately contribute to a large fraction (25 − 71%) of total blood repopulation." They described the fluctuations of tags that appeared in each sample as "waves of clones", but did not address why some clones can disappear at certain times and reappear in a latter sample.

In this study, we seek to better understand the observed clone size distributions and the large temporal variability in clonal populations. To address these observations, we ask: Is heterogeneity in HSCs necessary for peripheral blood clone size heterogeneity, or can a neutral model explain clone size differences? Are clones that disappear and reappear from sample to sample simply missed by random blood sampling, or do other mechanisms of temporal variability need to be invoked?

Unlike other previous models that describe the evolution of lineages of different cell types and their regulation \[[@pcbi.1006489.ref008]--[@pcbi.1006489.ref010], [@pcbi.1006489.ref021]\], we will consider simpler neutral models that describe the dynamics of specifically granulocyte populations carrying different tags. Of central interest is the competition among the thousands of clones under a neutral environment that gives rise to fluctuations, extinctions, and resurrections in individual clone populations. Even when considering only one cell type, realistic mathematical models may need to include complex multilevel biochemical feedback mechanisms of regulation \[[@pcbi.1006489.ref008], [@pcbi.1006489.ref022]--[@pcbi.1006489.ref027]\]. Many mechanisms may contribute to temporal fluctuations, including extrinsic noise and heterogeneity of HSCs, progenitors, or mature granulocytes. Large time gaps between samplings (5 − 11 months) and small sample sizes also add to the uncertainty of the underlying dynamics. Trying to infer all possible mechanisms and associated parameters from the experimental data would essentially be an overfitting problem. In order to feasibly compare with experimental data, our modeling philosophy will be to recapitulate these complexities into simple, effective models and infer parameters that subsume some of these regulatory effects. This approach and level of modeling are similar to those taken by *e.g*., Yang, Sun, and Komarova \[[@pcbi.1006489.ref028], [@pcbi.1006489.ref029]\].

After careful consideration of a number of key physiological mechanisms, we hypothesize that stochastic HSC self-renewal, generation-limited progenitor cell proliferation, and small-size sampling frequency statistics provide the simplest reasonable explanation for the observed clonal size variability and large temporal fluctuations. HSCs that are generated from self-renewal of the founder population share the same tag as their founder HSC. Thus, during intense self-renewal after myeloablative treatment and HSPC transplantation, each originally transplanted HSCs begets a clonal HSC subpopulation. Subsequently, heterogeneous clone sizes are stochastically generated even though each tag was initially represented by only a single cell. These expanded HSC clones then go on to repopulate the clones in the progenitor and mature blood population, which are also distinguishable by their corresponding tags.

Relative to HSCs, progenitor cells have limited proliferative potential that can explain the apparent extinctions of clones in blood samples. This limited proliferation potential can be thought of as an "aging" process. Different types of aging, including organism aging \[[@pcbi.1006489.ref023], [@pcbi.1006489.ref030], [@pcbi.1006489.ref031]\], replicative senescence of stem cells \[[@pcbi.1006489.ref032]\], and generation-dependent birth and death rates, have been summarized by Edelstein *et al*. \[[@pcbi.1006489.ref033]\]. Here, the clonal "aging" mechanism we invoke imposes a limit to the number of generations that can descend from each newly created (from HSC differentiation) "zeroth generation" progenitor cell. Possible sources of such a limit include differentiation-induced loss of division potential \[[@pcbi.1006489.ref034]\] and telomere shortening (as in the Hayflick limit) \[[@pcbi.1006489.ref035]--[@pcbi.1006489.ref037]\]. Mathematically, genealogical aging can be described by tracking cell populations within each generation. After a certain number of generations, progenitor cells of the final generation stop proliferating and can only differentiate into circulating mature cells or die.

In the following sections, we first present the mathematical equations and corresponding solutions (whenever possible) of a model that incorporates the above processes. We then develop a new statistical measure that tracks the numbers of absences of clones across the samples. Measured clone abundances of animal RQ5427 are statistically analyzed within our mechanistic model to infer estimates for key model parameters. The data and corresponding statistical analyses for animals 2RC003 and RQ3570 are also provided in the Results section.

Materials and methods {#sec002}
=====================

Below, we describe available clonal abundance data, mechanistic models, and a statistical model we will use for parameter inference.

Clone abundance data {#sec003}
--------------------

In the experiments of Kim *et al*. \[[@pcbi.1006489.ref013]\], cells in samples of peripheral blood were sequenced and counted to extract ${\hat{S}}^{+}\left( t_{j} \right)$, the total number of EGFP+ tagged cells in sample 1 ≤ *j* ≤ *J* taken at time *t*~*j*~. After PCR amplification and sequencing, ${\hat{f}}_{i}\left( t_{j} \right)$, the relative abundance of the *i*^th^ tag among all sampled, tagged cells is also quantified. The "\^" notation will henceforth indicate experimentally measured quantities.

Within mature peripheral blood, lymphocytes such as T cells and B cells proliferate or transform in response to unpredictable but clone-specific immune signals \[[@pcbi.1006489.ref038]\]. They also vary greatly in their lifespans, ranging from days in the case of regular T and B cells to years in the case of memory B cells. On the other hand, mature granulocytes do not proliferate in peripheral blood and have relatively shorter life spans \[[@pcbi.1006489.ref007]\]. Granulocyte dynamics can thus be analyzed with fewer confounding factors \[[@pcbi.1006489.ref011]\]. Thus, in this paper, we restrict our analysis to granulocyte repopulation and extract all variables, including ${\hat{S}}^{+}\left( t_{j} \right)$ and ${\hat{f}}_{i}\left( t_{j} \right)$ described above, that are associated exclusively with granulocyte populations.

In [Fig 1(a)](#pcbi.1006489.g001){ref-type="fig"}, we plot the total numbers of sampled granulocytes from one of the macaques, RQ5427. The subpopulation of EGFP+ granulocytes and the subset of EGFP+ granulocytes that were extracted for PCR amplification and analysis are also plotted. Data for two other animals, 2RC003 and RQ3570, are qualitatively similar. Blood samples from a fourth animal, 95E132, were not separated in to granulocyte and peripheral blood mononuclear cells (PBMCs) before sequencing. Thus, clonal abundances for granulocytes are not available from 95E132. There are only three animals for which we can analyze clonal abundances of granulocytes. For more specifics on the data, see supplemental files of the original experimental paper \[[@pcbi.1006489.ref013]\]. As shown in [Fig 1(b)](#pcbi.1006489.g001){ref-type="fig"}, not only are the clone abundances ${\hat{f}}_{i}\left( t_{j} \right)$ heterogeneous, but individual clone abundances vary across samples taken at different times. The variation is so large that many clones can go extinct and reappear from one sample to another, as shown in [Fig 1(c)](#pcbi.1006489.g001){ref-type="fig"}. Since large numbers of progenitor and mature cells are involved in blood production, the observed clone size fluctuations cannot arise from intrinsic demographic stochasticity of progenitor- and mature-cell birth and death. Moreover, we will show later in the Results section that random sampling alone cannot explain the observed clonal variances and mechanisms that involve other sources of variation are required.

![Blood sample data from animal RQ5427 \[[@pcbi.1006489.ref013]\].\
(a) The total numbers of sampled granulocytes (blue triangles), EGFP+ granulocytes (green squares), and the subset of EGFP+ granulocytes that were properly tagged and quantifiable were extracted for PCR amplification and analysis (black circles). This last population defined by ${\hat{S}}^{+}\left( t_{j} \right)$ is used to normalize clone cell counts. We excluded the first sample at month 2 in our subsequent analysis so, for example, the sample at month 56 is labeled the 7th sample. There were 536 clones detected at least once across the eight samples taken over 67 months comprising an average fraction 0.052 of all granulocytes. The abundances of granulocyte clones are shown in (b). The relative abundance ${\hat{f}}_{i}\left( t_{j} \right)$ of granulocytes from the *i*^th^ clone measured at month *t*~*j*~ is indicated by the vertical distances between two adjacent curves. The relative abundances of individual clones feature large fluctuations over time. "Extinctions" followed by subsequent "resurrections," were constantly seen in certain clones as indicated by the black circles in (b) and in the inset (c).](pcbi.1006489.g001){#pcbi.1006489.g001}

Nomenclature and lumped mechanistic model {#sec004}
-----------------------------------------

[Fig 2](#pcbi.1006489.g002){ref-type="fig"} depicts our neutral model of hematopoiesis which is composed of five successive stages, or compartments, describing the initial single-cell tagged HSC clonal populations immediately after transplantation (Compartment **0**), the heterogeneous HSC clonal populations after a short period of intense self-renewal (Compartment **1**), the transit-amplifying progenitor cell compartment (Compartment **2**), the peripheral blood pool (Compartment **3**), and the sampled peripheral blood (Compartment **4**), respectively. Each distinct color or shape in [Fig 2](#pcbi.1006489.g002){ref-type="fig"} represents a distinct clone of cells with the same tag.

![Schematic of a neutral multi-stage or multi-compartment hematopoiesis model.\
BM and PB refer to bone marrow and peripheral blood, respectively. Cells of the same clone have the same color. White circles represent untagged cells which were not counted in the analysis. Stages **0**, **1**, and **2** describe cell dynamics that occur mainly in the bone marrow. Stage **1** describes HSC clones (*C*~h~ = 6 in this example) after self-renewal that starts shortly after transplantation with rate *r*~h~. After self-renewal, the relatively stable HSC population (*H*^+^ = 20 in this example) shifts its emphasis to differentiation (with per-cell differentiation rate *α*). Larger clones in Stage **1** (*e.g*., the circular blue clone, *h*~blue~ = 4) will have a larger total differentiation rate *αh*~blue~ while smaller clones (*e.g*., the red hexagonal clone, *h*~red~ = 1) will have smaller *αh*~red~. The processes of progenitor-cell proliferation (with rate *r*~n~) and maturation (with rate *ω*) in Compartments **2** and **3** are considered deterministic because of the large numbers of cells involved. The darker-colored symbols correspond to cells of later generations. For illustration, the maximum number of progenitor-cell generations allowed is taken to be *L* = 4. Compartment **4** represents a small sampled fraction (*ε*(*t*~*j*~) ≈ 2.8 × 10^−5^ − 2 × 10^−4^) of Compartment **3**, the entire peripheral blood of the animal. In the example pictured above, *C*~s~ = 4. Such small samples can lead to considerable sampling noise but is not the key driver of sample-to-sample variability.](pcbi.1006489.g002){#pcbi.1006489.g002}

In each compartment, relevant parameters include (using Compartment **1** as example): the total cell count *H*(*t*), the untagged cell count *H*^−^(*t*), the tagged cell count *H*^+^(*t*), the total number of tagged clones *C*~h~(*t*), and the number *h*~*i*~(*t*) of HSCs carrying the *i*^th^ tag. These quantities are related through $\sum_{i = 1}^{C_{h}}h_{i}\left( t \right) = H^{+}\left( t \right) \equiv H\left( t \right) - H^{-}\left( t \right)$.

In the progenitor pool, the total number of cells and the number with tag *i* are denoted *N*(*t*) and *n*~*i*~(*t*), respectively. Further resolving these progenitor populations into those of the *ℓ*^th^ generation, we define *N*^(*ℓ*)^(*t*) and $n_{i}^{(\ell)}\left( t \right)$. In the mature granulocyte pool, the total granulocyte population and that with tag *i* are labelled *M*(*t*) and *m*~*i*~(*t*). In the sampled blood compartment, we use *S*(*t*~*j*~), *S*^+^(*t*~*j*~), *s*~*i*~(*t*~*j*~), and *C*~s~(*t*~*j*~) to denote, at time *t*~*j*~, the total number of sampled cells, the number of tagged sampled cells, the total number of tagged cells of clone *i*, and the total number of clones in the sample, respectively. In Compartment **4**, we further define *f*~*i*~(*t*~*j*~) = *s*~*i*~(*t*~*j*~)/*S*^+^(*t*~*j*~) to denote the relative abundance of the *i*^th^ clone among all tagged clones.

By lumping together all clones (tagged and untagged) in each compartment, we can readily model the dynamics of total populations in each pool. After myeloablative treatment, the number of BM cells, including HSCs, is severely reduced. Repopulation of autogolously transplanted HSCs occurs quickly via self-renewal until their total number *H*(*t*) reaches a steady-state. The repopulation of the *entire* HSC population and the subsequent entire progenitor and mature cell populations may be described via simple deterministic mass-action growth laws $$\begin{array}{r}
{\frac{dH\left( t \right)}{dt} = \left( r_{h}\left( H\left( t \right) \right) - \mu_{h} \right)H\left( t \right),} \\
\end{array}$$ $$\begin{array}{r}
{\frac{dN^{(\ell)}\left( t \right)}{dt} = \left\{ \begin{array}{ll}
{\alpha H\left( t \right) - \left( r_{n}^{(0)} + \mu_{n}^{(0)} \right)N^{(0)}\left( t \right),} & {\ell = 0,} \\
{2r_{n}^{(\ell - 1)}N^{(\ell - 1)}\left( t \right) - \left( r_{n}^{(\ell)} + \mu_{n}^{(\ell)} \right)N^{(\ell)}\left( t \right),} & {1 \leq \ell \leq L - 1,} \\
{2r_{n}^{(L - 1)}N^{(L - 1)}\left( t \right) - \left( \omega + \mu_{n}^{(L)} \right)N^{(L)}\left( t \right),} & {\ell = L,} \\
\end{array}\operatorname{} \right.} \\
\end{array}$$ $$\begin{array}{r}
{\frac{dM\left( t \right)}{dt} = \omega N^{(L)}\left( t \right) - \mu_{m}M\left( t \right).} \\
\end{array}$$ HSC self-renewal is a regulated process involving signaling and feedback \[[@pcbi.1006489.ref022]--[@pcbi.1006489.ref024], [@pcbi.1006489.ref039], [@pcbi.1006489.ref040]\] and *r*~h~ may be a complicated function of many factors; however, we will subsume this complexity into a simple population-dependent logistic growth law *r*~h~(*H*(*t*)) ≡ *p*~h~(1 − *H*(*t*)/*K*~h~) and assume a constant death rate *μ*~h~. Alternatively, other studies have employed Hill-type growth functions \[[@pcbi.1006489.ref012], [@pcbi.1006489.ref028]\].

We assume the per cell HSC differentiation rate *α* is independent of the tag and that differentiation is predominantly an asymmetric process by which an HSC divides into one identical HSC and one progenitor cell that commits to differentiation into granulocytes. An initial generation-zero progenitor cell further proliferates with rate $r_{n}^{(0)}$, contributing to the overall progenitor-cell population. Subsequent generation-*ℓ* progenitors, with population *N*^(*ℓ*)^, proliferate with rate $r_{n}^{(\ell)}$ until a maximum number of generations *L* is reached. By keeping track of the generation index *ℓ* of any progenitor cell, we limit the proliferation potential associated with an HSC differentiation event by requiring that any progenitor cell of the final *L*^th^ generation to terminally differentiate into peripheral blood cells with rate *ω* or to die with rate $\mu_{n}^{(L)}$. For simplicity, we neglect any other source of regulation and assume *α*, $\mu_{n}^{(\ell)} = \mu_{n}$, $r_{n}^{(\ell)} = r_{n}$ and *ω* are all unregulated constants.

Our model analysis and data fitting will be performed using clone abundances sampled a few months after transplantation under the assumption that granulopoiesis in the animals has reached steady-state \[[@pcbi.1006489.ref004]\] after initial intensive HSC self-renewal. Steady-state solutions of Eqs [(1)](#pcbi.1006489.e010){ref-type="disp-formula"}, [(2)](#pcbi.1006489.e011){ref-type="disp-formula"} and [(3)](#pcbi.1006489.e012){ref-type="disp-formula"} are defined by *H*~ss~, $N_{\text{ss}}^{(\ell)}$, and *M*~ss~. The first constraint our model provides relates these steady-state total populations through $$\begin{array}{r}
{M_{\text{ss}} = \frac{\omega}{\mu_{m}}N_{\text{ss}}^{(L)} = \frac{\omega}{\mu_{m}}\left\lbrack \frac{\alpha H_{\text{ss}}}{\left( \omega + \mu_{n}^{(L)} \right)}\left( \frac{2r_{n}}{r_{n} + \mu_{n}} \right)^{L} \right\rbrack \equiv \frac{A_{\text{ss}}\beta}{\mu_{m}},} \\
\end{array}$$ where we have defined $$\begin{array}{r}
{A_{\text{ss}} \equiv \alpha H_{\text{ss}},\text{and}\beta \equiv \frac{\omega}{\omega + \mu_{n}^{(L)}}\left( \frac{2r_{n}}{r_{n} + \mu_{n}} \right)^{L}} \\
\end{array}$$ as the total rate of HSC differentiation and the average number of granulocytes generated per HSC differentiation, respectively. These constraints also hold for the virally tagged, EGFP+ subset (about 5% − 10%) of HSCs, *e.g*., $M_{\text{ss}}^{+} = A_{\text{ss}}^{+}\beta/\mu_{m}$ and $A_{\text{ss}}^{+} = \alpha H_{\text{ss}}^{+}$. Since $M_{\text{ss}}^{+}$ is inferred from the experiment, [Eq (4)](#pcbi.1006489.e019){ref-type="disp-formula"} places a constraint between the total differentiation rate of labeled HSCs $A_{\text{ss}}^{+} = \alpha H_{\text{ss}}^{+}$ and the typical per-differentiation amplification number *β*. This steady-state constraint will eventually be combined with statistics of the fluctuating clone abundances data to infer estimates for the underlying model parameters.

Clone-resolved mechanistic model {#sec005}
--------------------------------

Although the lumped model above provides important constraints among the steady-state populations within each compartment, the clone-tracking experiment keeps track of the populations of sampled granulocytes that arise from "founder" HSCs that carry the same tag. Thus, we need to resolve the lumped model into the clonal subpopulations described by *h*~*i*~, $n_{i}^{(\ell)}$, and *m*~*i*~.

Even though the total HSC populations *H*(*t*) and *H*^±^(*t*) are large, the total number of clones *C*~h~ ≫ 1 in compartment **1** is also large, and the number of cells with any tag (the size of any clone) can be small. The population of cells with any specific tag *i* is thus subject to large demographic fluctuations. Thus, we model the stochastic population of HSCs of any tag using a master equation for *P*(*h*, *t*), the probability that at time *t* the number of HSCs of any clone is *h*: $$\begin{array}{r}
{\frac{dP\left( h,t \right)}{dt} = \mu_{h}\left( h + 1 \right)P\left( h + 1,t \right) + \left( h - 1 \right)r_{h}\left( H \right)P\left( h - 1,t \right) - \left\lbrack \mu_{h} + r_{h}\left( H \right) \right\rbrack hP\left( h,t \right).} \\
\end{array}$$ Recall that immediately after transplantation, each HSC carries a distinct tag before self-renewal (*h*~*i*~(0) = 1) leading to the initial condition $P\left( h,0 \right) = 1\left( h,1 \right)$, where the indicator function $1\left( x,y \right) = 1$ if and only if *x* = *y*. Because *h* = 0 is an absorbing boundary, clones start to disappear at long times resulting in a decrease in the total number *C*~h~(*t*) of HSC clones. Before this "coarsening" process significantly depletes the entire population, each clone constitutes a small subpopulation among all EGFP+ cells, *h*(*t*)≪*H*(*t*), and the stochastic dynamics of the population *h* of any clone can be approximated by the solution to [Eq (6)](#pcbi.1006489.e026){ref-type="disp-formula"} with the logistic self-renewal rate *r*~h~(*H*) ≡ *p*~h~(1 − *H*/*K*~h~) replaced by *r*~h~(*t*) = *p*~h~(1 − *H*(*t*)/*K*~h~). Hence, evolution of each HSC clone follows a generalized birth-death process with time-dependent birth rate and constant death rate. We show in Appendix A in [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"} that for *H* ≫ 1 the solution to [Eq (6)](#pcbi.1006489.e026){ref-type="disp-formula"} can be written in the form \[[@pcbi.1006489.ref041]\] $$\begin{array}{r}
{P\left( h,t \right) = \left( 1 - P\left( 0,t \right) \right)\left( 1 - \lambda\left( t \right) \right)\lambda\left( t \right)^{h - 1},} \\
\end{array}$$ where 0 ≤ λ(*t*) \< 1 depends on *r*~h~(*t*) and *μ*~h~. Here, λ(*t*) determines "broadness" (level of clone size heterogeneity) of the clone size distribution. For the relevant initial condition of unique tags at *t* = 0, λ(0) = 0 and λ(*t* → ∞)→1. When λ(*t*) is small, the distribution is weighted towards small *h*. For λ(*t*) = 0, $P\left( h,t \right) = 1\left( h,1 \right)$ which was the limit used in Goyal *et al*. \[[@pcbi.1006489.ref004]\] to assume no HSC self-renewal after transplantation. In the limit λ(*t*)→1, the distribution becomes flat and a clone is equally likely to be of any size 1 ≤ *h* ≤ *H*.

To further resolve the progenitor population into cells with distinct tags, we define *n*^(*ℓ*)^(*t*) as the number of generation-*ℓ* progenitor cells carrying any one of the viral tags. The total number of progenitor cells with a specific tag is $n\left( t \right) \equiv \sum_{\ell = 0}^{L}n^{(\ell)}\left( t \right)$. Since the sizes *h*~*i*~ of individual clones may be small, differentiation of HSCs within each clone may be rare. However, since the size of each tagged progenitor clone quickly becomes large (*n*(*t*) ≫ 1), we model the dynamics of *n*^(*ℓ*)^(*t*) using deterministic mass-action growth laws: $$\begin{array}{r}
{\frac{dn^{(\ell)}\left( t \right)}{dt} = \left\{ \begin{array}{ll}
{\text{Poisson}\left( \alpha h\left( t \right) \right) - \left( r_{n} + \mu_{n} \right)n^{(0)}\left( t \right),} & {\ell = 0,} \\
{2r_{n}n^{(\ell - 1)}\left( t \right) - \left( r_{n} + \mu_{n} \right)n^{(\ell)}\left( t \right),} & {1 \leq \ell \leq L - 1,} \\
{2r_{n}n^{(L - 1)}\left( t \right) - \left( \omega + \mu_{n}^{(L)} \right)n^{(L)}\left( t \right),} & {\ell = L.} \\
\end{array}\operatorname{} \right.} \\
\end{array}$$ Our model is neutral (all clones have the same birth, death, and maturation rates), so these equations are identical to [Eq (2)](#pcbi.1006489.e011){ref-type="disp-formula"}. However, since creation of the zeroth-generation subpopulation *n*^(0)^(*t*) derives only from differentiation of HSCs of the corresponding clone, which has a relatively small population *h*(*t*), we invoke a Poisson process with rate *αh*(*t*) to describe stochastic "injection" events associated with asymmetric differentiation of HSCs of said clone. Each discrete differentiation event leads to a temporal burst in *n*^(*ℓ*)^(*t*).

Finally, the dynamics of the population *m*(*t*) of any granulocyte clone in the peripheral blood are described by an equation analogous to [Eq (3)](#pcbi.1006489.e012){ref-type="disp-formula"}: $$\begin{array}{r}
{\frac{dm\left( t \right)}{dt} = \omega n^{(L)}\left( t \right) - \mu_{m}m\left( t \right),} \\
\end{array}$$ where we have assumed that only the generation-*L* progenitor cells undergo terminal differentiation with rate *ω*. An alternative model allows progenitor cells of earlier generations (*ℓ* \< *L*) to also differentiate and circulate but does not give rise to qualitatively different results (See Appendix B in [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"}).

To study the dynamics of the burst in $n_{b}^{(0)}\left( t \right)$ immediately following a *single, isolated* asymmetric HSC differentiation event at *t* = 0, we set the initial condition $n_{b}^{(0)}\left( 0 \right) = 1,\mspace{600mu} n_{b}^{(\ell)}\left( 0 \right) = 0\mspace{600mu}\left( 1 \leq \ell \leq L \right)$, remove the Poisson (*αh*(*t*)) term in [Eq (8)](#pcbi.1006489.e029){ref-type="disp-formula"} and find, $$\begin{array}{r}
{n_{b}^{(\ell)}\left( t \right) = \left\{ \begin{array}{ll}
{{\frac{\left( 2r_{n}t \right)^{\ell}}{\ell!}e^{- (r_{n} + \mu_{n})t}},} & {0 \leq \ell \leq L - 1,} \\
{2r_{n}\int_{0}^{t}n_{b}^{(L - 1)}\left( \tau \right)e^{- \omega(t - \tau)}d\tau,} & {\ell = L.} \\
\end{array}\operatorname{} \right.} \\
\end{array}$$ Bounded analytic solutions to $n_{b}^{(L)}\left( t \right)$ involving the lower incomplete gamma function can be found. Upon using the solution $n_{b}^{(L)}\left( t \right)$ in [Eq (9)](#pcbi.1006489.e030){ref-type="disp-formula"} the mature blood population within a clone associated with a single HSC clone differentiation even is described by $$\begin{array}{r}
{m_{b}\left( t \right) = \omega\int_{0}^{t}n_{b}^{(L)}\left( \tau \right)e^{- \mu_{m}{(t - \tau)}}d\tau.} \\
\end{array}$$ The populations associated with a single HSC differentiation event, $n_{b}^{(\ell)}\left( t \right)$ and *m*~b~(*t*), are plotted below in [Fig 3](#pcbi.1006489.g003){ref-type="fig"}. of the Results section. Then, the total number *m*~*i*~(*t*) of mature granulocytes with the *i*^th^ tag at time *t* is obtained by summing up all *m*~b~(*t* − *τ*~*k*~) bursts initiated by HSC differentiations at separate times *τ*~*k*~ ≤ *t* with the *i*^th^ tag.

![(a) A burst of cells is triggered by a single HSC differentiation event at time *t* = 0. A plot of representative solutions to Eqs [(10)](#pcbi.1006489.e033){ref-type="disp-formula"} and [(11)](#pcbi.1006489.e036){ref-type="disp-formula"} for *r*~n~ = 2.5, *L* = 24, $\mu_{n} = \mu_{n}^{(L)} = 0$, *μ*~m~ = 1, $A_{\text{ss}}^{+} = 14.7$, and *ω* = 0.16. Curves of different colors represent $n_{b}^{(\ell)}\left( t \right)$, the progenitor cell population within each generation *ℓ* = 0, 1, 2, ..., *L*, and *m*~b~(*t*), the number of mature granulocytes associated with the differentiation burst. All populations rise and fall. (b) Realizations of peripheral blood (PB) populations in a single clone arising from multiple successive differentiation events. The fluctuating populations are generated by adding together *m*~b~(*t*) associated with each differentiation event. Time series resulting from small (*h*~*i*~/*H*^+^ = 0.0003) and large (*h*~*i*~/*H*^+^ = 0.03) HSC clones are shown. Small clones are characterized by separated bursts of cells, after which the clone vanishes for a relatively long period of time. The number of mature peripheral blood cells of large clones reaches a relatively constant level and almost never vanishes.](pcbi.1006489.g003){#pcbi.1006489.g003}

Besides the burst dynamics described above, the data shown in [Fig 1(a)](#pcbi.1006489.g001){ref-type="fig"} are subject to the effects of small sampling size, uncertainty, and bias induced by experimental processing such as PCR amplification, and data filtering. In this experimental system, PCR generates a smaller uncertainty than blood sampling so we focus on the statistics of random sampling. Each blood sample drawn from monkey RQ5427 contains about 10*μ*g of genomic DNA \[[@pcbi.1006489.ref013]\]. After PCR amplification, deep sequencing, and data filtering, the total number ${\hat{S}}^{+}\left( t_{j} \right)$ of quantifiable tags corresponds to ∼5 × 10^3^ − 3 × 10^4^ tagged cells. The sample ratio is defined by $\varepsilon\left( t_{j} \right) \equiv {\hat{S}}^{+}\left( t_{j} \right)/{\hat{M}}_{\text{ss}}^{+} = 3 \times 10^{- 5} \sim 2 \times 10^{- 4}$ where ${\hat{M}}_{\text{ss}}^{+} \approx 1.6 \times 10^{8}$ is the estimated total number of tagged granuloctyes in the peripheral blood. The number of sampled cells with the *i*^th^ tag from the *j*^th^ sample then approximately follows a Binomial distribution $B\left( S^{+}\left( t_{j} \right),\frac{m_{i}\left( t_{j} \right)}{M_{\text{ss}}^{+}} \right) \approx B\left( m_{i}\left( t_{j} \right),\varepsilon\left( t_{j} \right) \right)$ in our model. To quantitatively explore the feature of apparent extinctions of clones from a sample, we calculate the probability that no peripheral blood cell from clone *i* is found in a sample of size ${S^{+}\left( t_{j} \right) ⪡ M_{\text{ss}}^{+}}{:P\left( f_{i}\left( t_{j} \right) = 0 \middle| {m_{i}\left( t_{j} \right)} \right) = \binom{M_{\text{ss}}^{+} - {m_{i}\left( t_{j} \right)}}{S^{+}\left( t_{j} \right)}/\binom{M_{\text{ss}}^{+}}{S^{+}\left( t_{j} \right)} \approx \exp\left( - \frac{{m_{i}\left( t_{j} \right)}S^{+}\left( t_{j} \right)}{M_{\text{ss}}^{+}} \right)}$. Thus, if ${m_{i}\left( t_{j} \right)} < \varepsilon^{- 1} = {\hat{M}}_{\text{ss}}^{+}/{\hat{S}}^{+}\left( t_{j} \right) \sim 2 \times 10^{4}$ the *i*^th^ clone is likely to be missed in the sample. The value *ε*^−1^ is also used to threshold the population *m*~b~(*t*) to define the measurable duration Δ*τ*~b~ of a burst (as indicated in [Fig 3(a)](#pcbi.1006489.g003){ref-type="fig"}).

Parameter values {#sec006}
----------------

Parameters determined by the experimental procedure or estimated directly from the experiments include the weight of the animal, the sampling times *t*~*j*~, the EGFP+ ratio, and the total number of tagged cells detected in each sample ${\hat{S}}^{+}\left( t_{j} \right)$. Since the tagged granulocyte population ${\hat{M}}^{+}\left( t_{j} \right)$ does not fluctuate much across samples, we use its average for ${\hat{M}}_{\text{ss}}^{+}$, and the relevant experimental parameters for each animal become $\theta_{\text{exp}} = \left\{ {\hat{M}}_{\text{ss}}^{+},{\hat{S}}_{i}^{+}\left( t_{j} \right),t_{j} \right\}$. These will also be used as inputs to our models.

Our multi-stage model also contains many other intrinsic parameters, including $\theta_{\text{model}} = \left\{ \lambda,C_{h},\alpha,r_{n},\mu_{n},\mu_{n}^{(L)},L,\omega,\mu_{m} \right\}$. We first found parameter values that have been reliably independently measured. Some parameters were measured in human clinical studies rather than in rhesus macaques but can nonetheless serve as reasonable approximations for non-human primates due to multiple physiological similarities \[[@pcbi.1006489.ref042]\]. These estimates can certainly be improved once direct measurements on rhesus macaques become available. Model parameters, their estimates, and the associated references are given in [Table 1](#pcbi.1006489.t001){ref-type="table"} below.

10.1371/journal.pcbi.1006489.t001

###### Summary of parameters, including their biological interpretation, ranges of values, and references.

All rate parameters are quoted in units of per day. Other parameters are chosen to be within their corresponding reported ranges from the referenced literature. How variations in parameter values affect our analysis will be described in the subsequent sections.

![](pcbi.1006489.t001){#pcbi.1006489.t001g}

  Parameter                                                    Interpretation                                                  Values & References
  ------------------------------------------------------------ --------------------------------------------------------------- ------------------------------------------------------------------------------------------------------
  **HSC pool** (Compartment **1**)                                                                                             
  *H*~ss~                                                      total number of HSCs at steady state                            1.1 × 10^4^ − 1.1 × 10^6^ \[[@pcbi.1006489.ref004], [@pcbi.1006489.ref011], [@pcbi.1006489.ref012]\]
  *α*                                                          per-cell HSC differentiation rate                               5.6 × 10^−4^ − 0.02 \[[@pcbi.1006489.ref004], [@pcbi.1006489.ref011], [@pcbi.1006489.ref012]\]
  *μ*~h~                                                       HSC death rate                                                  10^−3^ − 0.1 \[[@pcbi.1006489.ref012], [@pcbi.1006489.ref034]\]
  **Transit-Amplifying Progenitor pool** (Compartment **2**)                                                                   
  *r*~n~                                                       growth rate of progenitor cell                                  2 − 3 \[[@pcbi.1006489.ref012]\]
  *μ*~n~                                                       death rate of progenitor cell (generation *ℓ* \< *L*)           0 \[[@pcbi.1006489.ref012], [@pcbi.1006489.ref034]\]
  $\mu_{n}^{(L)}$                                              death rate of progenitor cell (generation *ℓ* = *L*)            0 − 0.27 \[[@pcbi.1006489.ref012], [@pcbi.1006489.ref034]\]
  *ω*                                                          maturation rate of generation-*L* cells                         0.15 − 0.17 \[[@pcbi.1006489.ref043], [@pcbi.1006489.ref044]\]
  *L*                                                          maximum generation of progenitor cells                          15 − 21 \[[@pcbi.1006489.ref012], [@pcbi.1006489.ref034]\]
  **Peripheral Blood pool** (Compartment **3**)                                                                                
  *M*~ss~                                                      total number of peripheral blood granulocytes at steady state   (2.5 − 5) × 10^9^ \[[@pcbi.1006489.ref013], [@pcbi.1006489.ref042]\]
  *μ*~m~                                                       death rate of peripheral blood granulocytes                     0.2 − 2 \[[@pcbi.1006489.ref034], [@pcbi.1006489.ref044], [@pcbi.1006489.ref045]\]

Model properties and implementation {#sec007}
-----------------------------------

Using parameter estimates, we summarize the dynamical properties of our model and describe how the key model ingredients including stability of HSC clone distributions and subsequent "bursty" clone dynamics that follow differentiation can qualitatively generate the observed clone-size variances.

*Slow homeostatic birth-death of HSCs---*The first important feature to note is the slow homeostatic birth-death of HSCs. After the bone marrow is quickly repopulated, *r*~h~(*H*(*t*)) − *μ*~h~ ≈ 0, and stochastic self-renewal slows down. Because *h* = 0 is an absorbing state, the size distribution of the clones may still slowly evolve and coarsen due to stochastic dynamics, leading to the slow successive extinction of smaller clones. The typical timescale for overall changes in *h* can be estimated by approximating *r*~h~(*H*~ss~) ≈ *μ*~h~ \[[@pcbi.1006489.ref046]\] and considering the mean time *T*(*h*) of extinction of a clone initially at size *h* ⪡ *H*~ss~. The standard result given in Gardiner \[[@pcbi.1006489.ref047]\] and also derived in Appendix C in [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"} is $T\left( h \right) \approx \frac{h}{\mu_{h}}\left( 1 + \ln\frac{H_{\text{ss}}}{h} \right) \gtrsim 10^{2}$ months (for *μ*~h~ = 10^−2^, *H*~ss~ = 10^4^, *h* = 10^1^; see [Table 1](#pcbi.1006489.t001){ref-type="table"} for applicable values). Since this timescale is larger than the time of the experiment (67 months for monkey RQ5427), mean HSC clone sizes do not change dramatically during the experiment, consistent with the stable number of clones observed in the samples shown in [Fig 1(b)](#pcbi.1006489.g001){ref-type="fig"}. Thus, as a first approximation, we will use a static configuration {*h*~*i*~} drawn from *P*(*h*) to describe how, through differentiation, HSC clones feed the progenitor pool.

*Fast clonal aging of progenitors---*In contrast to slow HSC coarsening, progenitor cells proliferate "transiently." In [Fig 3(a)](#pcbi.1006489.g003){ref-type="fig"} we plot a single population burst of progenitor and mature granulocytes, given by Eqs [(10)](#pcbi.1006489.e033){ref-type="disp-formula"} and [(11)](#pcbi.1006489.e036){ref-type="disp-formula"} and using the parameter values listed in [Table 1](#pcbi.1006489.t001){ref-type="table"}. The characteristic duration, or "width" Δ*τ*~b~ associated with each temporal burst of cells is defined as the length of time during which the number *m*~b~(*t*) is above the detection threshold within a sample of peripheral blood: $\varepsilon^{- 1} = {\hat{M}}_{\text{ss}}^{+}/{\hat{S}}^{+} \approx 2 \times 10^{4}$.

According to [Eq (11)](#pcbi.1006489.e036){ref-type="disp-formula"}, the burst width and height depend nonlinearly on the parameters *L*, *r*~n~, *μ*~n~, *μ*~m~, and *ω* in their physiological ranges (see [Table 1](#pcbi.1006489.t001){ref-type="table"}). The characteristic width of a burst scales as Δ*τ*~b~ ∼ *L*/*r*~n~ + 1/*ω* + 1/*μ*~m~. This estimate is derived by considering the *L* rounds of progenitor cell division, each of which takes time ∼ 1/*r*~n~. Terminal-generation progenitors then require time ∼1/*ω* to mature, after which mature granulocytes live for time ∼ 1/*μ*~m~. In total, the expected life span of ∼ *L*/*r*~n~ + 1/*ω* + 1/*μ*~m~ approximates the timescale of a HSC-differentiation-induced burst of cells fated to be granulocytes. Using realistic parameter values, the typical detectable burst duration Δ*τ*~b~ ∼ 1 − 2 months is much shorter than the typical sampling gaps Δ*t*~*j*~ = 5 − 11 months.

With this "burst" picture in mind, we now show how fluctuations of sampled clone sizes can be explained. Small-*h* (where the clone-wise HSC differentiation rate $\alpha h_{i} ⪡ \frac{1}{\Delta\tau_{b}}$) clones rarely appear in blood samples. Their appearance also depends on whether sampling is frequent and sensitive enough to catch the burst of cells after rare HSC differentiation events. On the other hand, large-*h* ($\alpha h_{i} \gg \frac{1}{\Delta\tau_{b}}$) clones differentiate frequently and consistently appear in the peripheral blood. Their populations in blood samples are less sensitive to the frequency of taking samples. [Fig 3(b)](#pcbi.1006489.g003){ref-type="fig"} shows two multi-burst realizations of peripheral-blood populations *m*~*i*~(*t*) of clone *i* corresponding to a small clone and a large clone. The 2000-day trajectories were simulated by fixing *h*~*i*~ and stochastically initiating the progenitor proliferation process. Population bursts described by [Eq (11)](#pcbi.1006489.e036){ref-type="disp-formula"} were added after each differentiation event distributed according to Poisson(*αh*~*i*~). Using simulations, we confirm that the statistics of clone extinctions and resurrections are more sensitive to the overall clonal differentiation rate *αh*~*i*~ than to the precise shape of a mature cell burst, allowing a reduction in the number of effective parameters (Appendix D in [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"}).

We can further pare down the number of remaining parameters by finding common dependences in the model and defining an effective maximum generation number. We can rewrite [Eq (5)](#pcbi.1006489.e020){ref-type="disp-formula"} as $\beta \equiv 2^{L_{e}}$, where $$\begin{array}{r}
{L_{e} = L - L\log_{2}\left\lbrack \frac{r_{n} + \mu_{n}}{r_{n}} \right\rbrack - \log_{2}\left\lbrack \frac{\omega + \mu_{n}^{(L)}}{\omega} \right\rbrack} \\
\end{array}$$ is an *effective* (and noninteger) maximum generation parameter. Later in Appendix D in [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"}, we show that uncertainties of the model structure, alternative mechanisms, and parameter values can be subsumed into *L*~e~. Henceforth, in our quantitative data analysis, we will set the unmeasurable parameters $\mu_{n} = \mu_{n}^{(L)} = 0$ and subsume their uncertainties into an effective maximum generation *L*~e~. Finally, we will invoke [Eq (4)](#pcbi.1006489.e019){ref-type="disp-formula"} to find the constraint $$\begin{array}{r}
{A_{\text{ss}}^{+}\beta = A_{\text{ss}}^{+}2^{L_{e}} = M_{\text{ss}}^{+}\mu_{m}.} \\
\end{array}$$ Since we can estimate $M_{\text{ss}}^{+}$ of the animals in the experiment and the death rate of mature granulocytes *μ*~m~ has been reliably measured in the literature, [Eq (13)](#pcbi.1006489.e060){ref-type="disp-formula"} provides a relationship between the total steady-state differentiation rate $A_{\text{ss}}^{+}$ and the maximum number of progenitor generations *L*~e~.

After assigning values to parameters using [Table 1](#pcbi.1006489.t001){ref-type="table"} (setting *μ*~n~ = 0, *ω* = 0.16 and *μ*~m~ = 1), subsuming parameters into *L*~e~ (setting $\mu_{n}^{(L)} = 0$), describing the configuration {*h*~*i*~} through the distribution shape factor λ and the total number of HSC clones *C*~h~ (setting the HSC death rate *μ*~h~ = 0), and applying the constraint $A_{\text{ss}}^{+}2^{L_{e}} = {\hat{M}}_{\text{ss}}^{+}\mu_{m}$, we are left with four effective model parameters *θ*~model~ = {λ, *C*~h~, *r*~n~, *L*~e~}. Here we have included *r*~n~ in the key model parameters since it is not reliably measured and the cell burst width is sensitive to *r*~n~. Once *L*~e~ is inferred, [Eq (13)](#pcbi.1006489.e060){ref-type="disp-formula"} can be used to find $A_{\text{ss}}^{+} = 2^{- L_{e}}{\hat{M}}_{\text{ss}}^{+}\mu_{m}$.

Statistical model {#sec008}
-----------------

The total number of tags observed across all samples (obtained by summing up the observed numbers of *unique* tags over *J* samples) can be used as a lower bound on *C*~h~. Even though estimates for animal RQ5427 give *C*~h~ ∼ 550 − 1100, uncertainties in the HSC self-renewal rate parameters *p*~h~, *K*~h~, and the initial HSC population *H*(0) make λ and *P*(*h*, *t*) difficult to quantify. Even if *P*(*h*, *t*) were known, it is unlikely that the drawn {*h*~*i*~} would accurately represent those in the monkey, especially when λ ≈ 1 and *P*(*h*) becomes extremely broad (the variance of *P*(*h*) approaches infinity). Thus, we are motivated to find a statistical measure of the data that is insensitive to the exact configuration of {*h*~*i*~}. The goal is to study the statistical correlations between various features of *only* the outputs, which should be insensitive to the input configuration {*h*~*i*~} but still encode information about the differentiation dynamics.

Two such features commonly used to fit simulated *f*~*i*~(*t*~*j*~) to measured ${\hat{f}}_{i}\left( t_{j} \right)$ are the mean $y_{i} = \frac{1}{J}\sum_{j = 1}^{J}f_{i}\left( t_{j} \right)$ and the variance $\sigma_{i}^{2} = \frac{1}{J}\sum_{j = 1}^{J}\left( f_{i}\left( t_{j} \right) - y_{i} \right)^{2}$. However, the small number of measurement time points *J* and the frequent disappearance of clones motivated us to propose an even more convenient statistic that is based on $$\begin{array}{r}
{z_{i} = \sum\limits_{j}1\left( f_{i}\left( t_{j} \right),0 \right),} \\
\end{array}$$ the number of absences across all samples of a clone rather than on *σ*~*i*~. Here, the indicator function $1\left( x,x\prime \right) = 1$ when *x* = *x*′ and $1\left( x,x\prime \right) = 0$ otherwise. In Appendix E in [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"}, we illustrate alternatives such as data fitting based on *σ*~*i*~ and on an autocorrelation function but also describe the statistical insights gained from using statistics of *z*~*i*~.

The level of correlation between the observed number ${\hat{z}}_{i}$ of absences of clone *i* and its average abundance ${\hat{y}}_{i}$ is measured by the average of ${\hat{y}}_{i}$ conditioned on ${\hat{z}}_{i}$ (dashed curve). In [Fig 4](#pcbi.1006489.g004){ref-type="fig"}, the distribution of the values of ${\hat{y}}_{i}$ at each ${\hat{z}}_{i}$ is clearly shown. To combine the correlated stochastic quantities *z*~*i*~ and *y*~*i*~ into a useful objective function, we take the expectation of *y*~*i*~ over only those clones that have a specific number *z*~*i*~ = *z* absences across the time samples: $$\begin{array}{r}
{Y_{z} = \frac{\sum_{i}y_{i}\, 1\left( z_{i},z \right)}{\sum_{i}1\left( z_{i},z \right)}.} \\
\end{array}$$ The normalizing denominator $\sum_{i}1\left( z_{i},z \right)$ is simply the number of clones with exactly *z* absences. In case no simulated or data-derived trajectories *f*~*i*~(*t*~*j*~) exhibit exactly *z* absences, we set *Y*~*z*~ = 0 or ${\hat{Y}}_{z} = 0$. We then determine *Y*~*z*~(*θ*~model~) from simulating our model and ${\hat{Y}}_{z}$ from experiment and use the mean squared error (MSE) between the two as the objective function: $$\begin{array}{r}
{\text{MSE}\left( \theta_{\text{model}} \right) = \sum\limits_{z = 1}^{J - 1}\left\lbrack Y_{z}\left( \theta_{\text{model}} \right) - {\hat{Y}}_{z} \right\rbrack^{2},} \\
\end{array}$$ where *θ*~model~ = {λ, *C*~h~, *r*~n~, *L*~e~}. *Y*~0~ is excluded from the MSE calculation because the *y*~*i*~ values of clones that have *z*~*i*~ = 0 are not constrained by the burstiness of the model and *Y*~0~ can be sensitive to the underlying configuration {*h*~*i*~} (see the [Discussion](#sec015){ref-type="sec"} and Appendix E in [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"}).

![Scatterplot of clone trajectories of animal RQ5427 displayed in terms of ln ${\hat{y}}_{i}$, the log mean abundance of clone *i*, and ${\hat{z}}_{i}$, the number of samples in which clone *i* is undetected.\
The trajectory of each clone *i* is represented by a symbol located at a coordinate determined by its value of ln ${\hat{y}}_{i}$ and ${\hat{z}}_{i}$. A trajectory of a clone that exhibits one absence within months 8 − 67 is shown in the inset. The first sample at month 2 is excluded because only long-term repopulating clones are considered. Clones that are absent in all eight samples are also excluded, so the largest number of absences considered for animal RQ5427 is 7. The dashed black line denotes ln ${\hat{Y}}_{z}$, where ${\hat{Y}}_{z}$ is the average of ${\hat{y}}_{i}$ calculated over *i* within each bin of *z* as shown in [Eq (15)](#pcbi.1006489.e077){ref-type="disp-formula"}. When later analyzing ${\hat{Y}}_{z}$, ${\hat{Y}}_{0}$ (red circles) is not included.](pcbi.1006489.g004){#pcbi.1006489.g004}

We are now in a position to compare results of our model with experimental data. The general approach will be to choose a set of parameters, simulate the forward model (including sampling) to generate clone abundances {*f*~*i*~(*t*~*j*~)}, number of absences *z*~*i*~, and ultimately *Y*~*z*~(*θ*~model~), which is then compared to data-derived ${\hat{Y}}_{z}$. By minimizing [Eq (16)](#pcbi.1006489.e081){ref-type="disp-formula"} with respect to *θ*~model~, we obtain the least square estimates (LSE) of *θ*~model~. A schematic of our workflow is shown in [Fig 5](#pcbi.1006489.g005){ref-type="fig"}. We describe the details of the simulation of our model in Appendix F in [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"}.

![Workflow for comparing parameter-dependent simulated data with measured clone abundances.\
The first step is drawing a configuration {*h*~*i*~}, which is experimentally unmeasurable, from the HSC clone distribution *P*(*h*). To define *P*(*h*) requires an initial estimate of λ and *C*~h~. Using known experimental parameters *θ*~exp~ and choosing *r*~n~, *L*~e~ ∈ *θ*~model~, we compute the theoretical quantities *y*~*i*~ and *z*~*i*~ by simulating the multi-compartment mechanistic model and the peripheral-blood sampling. The corresponding ${\hat{y}}_{i}$ and ${\hat{z}}_{i}$ are extracted from data, and the theoretical *Y*~z~(*θ*~model~) and the experimental ${\hat{Y}}_{z}$ are compared through the MSE defined in [Eq (16)](#pcbi.1006489.e081){ref-type="disp-formula"}. The MSE is then minimized to find least squares estimates for *θ*~model~.](pcbi.1006489.g005){#pcbi.1006489.g005}

Results {#sec009}
=======

By implementing the protocol outlined in [Fig 5](#pcbi.1006489.g005){ref-type="fig"}, we find a number of results including least-squares-estimates (LSE) of the parameters, their sensitivity to other model features, validation of the mechanistic model, and robustness of our statistical methods to missing data and clone sampling thresholds. Our analyses allow us to effectively compare the results from the three different animals.

MSE function and estimates of *L*~e~ and $A_{\text{ss}}^{+}$ for animal RQ5427 {#sec010}
------------------------------------------------------------------------------

We first fix the HSC distribution shape parameter λ = 0.99 and the total number of HSC clones *C*~h~ = 500; this choice will be justified in the next subsection. The MSE objective function can now be plotted as a function of the proliferation rate *r*~n~ ∈ \[0.01, 10\] and proliferation potential *L*~e~ ∈ \[19, 28\] of progenitor cells in their respective biologically relevant ranges. Even after specifying *θ*~model~ = {λ = 0.99, *C*~h~ = 500, *r*~n~, *L*~e~}, there is still uncertainty in the simulated values of *Y*~*z*~ = {*Y*~1~, *Y*~2~, ..., *Y*~7~} due to the uncertainty in the drawn configuration of HSC clone sizes {*h*~*i*~}, the intrinsic stochastic mechanisms of the model (Poissonian HSC differentiation events), and random peripheral blood sampling. Therefore, we performed 200 simulations for each set of {*r*~n~, *L*~e~}, producing 200 sets of *Y*~*z*~. The means of *Y*~*z*~ are used to construct the mean of MSE(λ = 0.99, *C*~h~ = 500, *r*~n~, *L*~e~), plotted in [Fig 6](#pcbi.1006489.g006){ref-type="fig"}.

![Dependence of the mean MSE defined in [Eq (16)](#pcbi.1006489.e081){ref-type="disp-formula"} on *r*~n~ and *L*~e~.\
For visualization purposes, we took the natural logarithms of MSE values and plotted them as a function of *L*~e~ and *r*~n~. Blue areas denotes smaller MSE values, thus better fitting. This energy surface was generated by averaging over 200 simulations using *C*~h~ = 500 and λ = 0.99.](pcbi.1006489.g006){#pcbi.1006489.g006}

In the reported progenitor growth rate range of *r*~n~ = 2 − 3 ([Table 1](#pcbi.1006489.t001){ref-type="table"}), the MSE function is quite insensitive to *L*~e~. To interpret this observation, note that *r*~n~ does not affect the absolute value of *β* according to [Eq (13)](#pcbi.1006489.e060){ref-type="disp-formula"}, but it affects the typical time ∼ *L*/*r*~n~ + 1/*ω* it takes for a generation 0 progenitor cell to form a mature granulocyte. When *r*~n~ \< *μ*~m~, the proliferation of progenitors cannot "catch up" with the loss of granulocytes, resulting in a quickly vanishing burst in the granulocyte population *m*~b~(*t*) arising from a single-differentiation event *m*~b~(*t*). A larger *L*~e~ would be required to compensate. When *r*~n~ ≫ *μ*~m~, the growth of any clone is much quicker than its loss, so the burst size is relatively stable and $L_{e}^{*}$ is not very sensitive to *r*~n~. Thus, the MSE objective function is fairly insensitive to *r*~n~ in its biologically meaningful value range.

We then fix the progenitor proliferation rate *r*~n~ = 2.5 and plot the mean MSE(λ = 0.99, *C*~h~ = 500, *r*~n~ = 2.5, *L*~e~) in [Fig 7(a)](#pcbi.1006489.g007){ref-type="fig"}, which indicates a clear minimum at $L_{e}^{*} = 23.4 \pm 0.12$. The error bars denote the standard deviation of MSEs obtained from the 200 simulations at different values of *L*~e~ and show that the variability is negligible for the purpose of determining the minimum. Upon applying the steady-state granulocyte balance constraint in [Eq (13)](#pcbi.1006489.e060){ref-type="disp-formula"}, we obtain a total HSC differentiation rate $\left( A_{\text{ss}}^{+} \right)^{*} = 14.7$.

![Finding the least squares estimate (LSE) $L_{e}^{*}$ for animal RQ5427 by fitting the simulated *Y*~*z*~ to the experimental ${\hat{Y}}_{z}$.\
The values of (λ, *C*~h~, *r*~n~) are chosen to be (0.99, 500, 2.5). Simulations with {*h*~*i*~} set to $\left\{ {\hat{y}}_{i} \right\} H_{\text{ss}}^{+}$ instead of drawing from *P*(*h*) generate similar results. (a) The LSE is $L_{e}^{*} = 23.4$. Averages and standard deviations (error bars) of the 200 MSEs are plotted. (b) Comparisons between the experimental (solid) ${\hat{Y}}_{z}$ and simulated (dashed) *Y*~*z*~ with fixed $L_{e}^{*} = 23.4$. The error bars are determined by considering the standard deviation of the average abundances (*y*~*i*~ or ${\hat{y}}_{i}$) of all clones exhibiting *z* absences.](pcbi.1006489.g007){#pcbi.1006489.g007}

If we approximate $\mu_{n},\mu_{n}^{(L)} = 0$, *L*~*e*~ ≈ *L*. Substituting LSE values $L_{e}^{*} = 23.4$ for *L* into the model for the peripheral blood bursts (the analytic solutions to *n*^(*L*)^(*t*) and *m*~b~(*t*) in Eqs [(10)](#pcbi.1006489.e033){ref-type="disp-formula"} and [(11)](#pcbi.1006489.e036){ref-type="disp-formula"}) yields a single burst duration of Δ*τ*~b~ ≈ 32 days, consistent with our assumption Δ*τ*~b~ ⪡ Δ*t*~j~ = 5 − 11 months. Note that even though *L* is interpreted as an integer in [Eq (8)](#pcbi.1006489.e029){ref-type="disp-formula"}, analytic solutions of Eqs [(10)](#pcbi.1006489.e033){ref-type="disp-formula"} and [(11)](#pcbi.1006489.e036){ref-type="disp-formula"}, $n_{b}^{(\ell)}\left( t \right)$ and *m*~b~(*t*), depend on *L* in a continuous manner, interpolating the behavior to arbitrary values of *L*. [Fig 7(b)](#pcbi.1006489.g007){ref-type="fig"} shows how *one* simulation of $Y_{z}\left( L_{e}^{*} = 23.4 \right)$ fits the experimentally measured ${\hat{Y}}_{z}$. Here, each error bar denotes the standard deviation across all mean abundances *y*~*i*~ (or ${\hat{y}}_{i}$) within each value of *z* absences.

Insensitivity of analysis to HSC configurations {#sec011}
-----------------------------------------------

In [Fig 8](#pcbi.1006489.g008){ref-type="fig"}, we demonstrate the weak dependence of our least-squares estimate to λ, the parameter controlling the shape of the probability distribution of HSC clone sizes *P*(*h*, *t*). For each λ, we sample a fixed number (*C*~h~ = 500) of HSC clones from the theoretical distribution *P*(*h*, *t*), fix *r*~n~ = 2.5, and let *L*~e~ vary between 19 and 28. The averages of the 200 simulated MSEs at each value of *L*~e~ are compared and the $L_{e}^{*}$ that corresponds to the minimal average MSE is selected. The selected $L_{e}^{*}$ as a function of λ is plotted in [Fig 8(a)](#pcbi.1006489.g008){ref-type="fig"}. [Fig 8(b)](#pcbi.1006489.g008){ref-type="fig"} shows the averages and standard deviations of MSE $\left( L_{e}^{*} \right)$ at each value of λ. We then repeat the simulations with *C*~h~ = 1000. These results together show that $L_{e}^{*}$ is insensitive to the distribution of *h*~*i*~. This insensitivity might be understood by noticing that the quantity *Y*~*z*~ is defined as the *mean* of the values of *y*~*i*~ that are associated with *z* absences (dashed curve in [Fig 4](#pcbi.1006489.g004){ref-type="fig"}) and is not necessarily sensitive to how these values are distributed (vertically distributed markers at each value of *z* in [Fig 4](#pcbi.1006489.g004){ref-type="fig"}). Instead, *Y*~*z*~ incorporates the intrinsic relationship between a clone's mean abundance *y*~*i*~ and its number of absences *z*~*i*~, averaged over all clones. It thus also encodes how heterogeneity in the HSC clone populations is translated into the burstiness seen in the sampled clone abundances *f*~*i*~(*t*~*j*~). Although it is generally impossible to recover the exact {*h*~*i*~} configuration, we find the HSC self-renewal-induced geometric distribution described by [Eq (7)](#pcbi.1006489.e027){ref-type="disp-formula"} generally generates better fits to the sampled data when λ is large (≳ 0.5), suggesting significant heterogeneity in values of *h*~*i*~.

![The LSE $L_{e}^{*}$ is insensitive to the geometric distribution factor λ \> 0 and to *C*~h~ ≫ 1.\
This implies that for a wide range of values of λ and *C*~h~ the LSEs are insensitive to the HSC configuration {*h*~*i*~}. (a) $L_{e}^{*}$ s found at each value of λ. (b) Averages and standard deviations (error bars) of MSE $\left( L_{e}^{*} \right)$ as a function of λ. The LSE and MSE($L_{e}^{*}$) values associated with self-consistently using $\left\{ h_{i} \right\}/H^{+} = \left\{ {\hat{y}}_{i} \right\}$ from experimental data are marked by arrows and "exp."](pcbi.1006489.g008){#pcbi.1006489.g008}

Comparison of variability from simple sampling and best-fit model {#sec012}
-----------------------------------------------------------------

We can check how our LSE result performs against the null hypothesis that clone size variations arise only from random sampling. An estimate of sampling-induced variability can be obtained by assuming a specific number of peripheral blood granulocytes of tag *i* and randomly drawing an experimentally determined fraction *ε*(*t*~*j*~) of peripheral blood cells. This is repeated *J* times from a constant peripheral pool {*m*~*i*~}. Each draw results in *s*~*i*~(*t*~*j*~) cells of clone *i* in the simulated sample. Normalizing by *S*^+^(*t*~*j*~), the total number of tagged cells in the sample, we obtain simulated *f*~*i*~(*t*~*j*~) from which we extract the mean abundance *y*~*i*~ and its standard deviation $\sigma_{i} = \sqrt{\frac{1}{J}\sum_{j = 1}^{J}\left( f_{i}\left( t_{j} \right) - y_{i} \right)^{2}}$ for each clone *i*. The simulated quantities ln *y*~*i*~ and *σ*~*i*~ associated with each clone *i* are indicated by the green triangles in [Fig 9(a)](#pcbi.1006489.g009){ref-type="fig"}. The corresponding values $\ln{\hat{y}}_{i}$ and ${\hat{\sigma}}_{i}$ derived from the data shown in [Fig 1(b)](#pcbi.1006489.g001){ref-type="fig"} are indicated by the blue dots. This simple heuristic test shows that the experimental fluctuations in clone abundances are significantly larger than those generated from random sampling alone and that additional mechanisms are responsible for the fluctuation of clone abundances in peripheral blood. Using LSE parameter values, [Fig 9(b)](#pcbi.1006489.g009){ref-type="fig"} shows the fluctuations in clone abundances obtained from random sampling of fluctuating mature clones simulated from our model. Here, the variability is a convolution of the fluctuations arising from intrinsic burstiness and from random sampling. The total variability fits those of the experimental data well except for several large-sized outlier clones.

![(a) A plot of the standard deviation ${\hat{\sigma}}_{i}$ *vs*. the log of the mean ${\hat{y}}_{i}$, extracted from abundance data (blue dots). For comparison, clonal tags distributed within the peripheral blood cells were randomly sampled (with the same sampling fraction *ε*(*t*~*j*~) at times *t*~*j*~ as in the experiment). The analogous quantity *σ*~*i*~ shown by the green triangles indicates a much lower standard deviation for a given value of ln *y*~*i*~. This simple test implies that the clonal variability across time cannot be explained by random sampling. (b) The same test is performed after applying our model with the LSE parameter *L*~e~ = 23.4 (and the average of parameters listed in [Table 1](#pcbi.1006489.t001){ref-type="table"}).](pcbi.1006489.g009){#pcbi.1006489.g009}

Robustness of $L_{e}^{*}$ to sampling frequency and threshold {#sec013}
-------------------------------------------------------------

We checked the robustness of our inference by leaving out time points from the experiment. Recall that the experimental data matrix for animal RQ5427 contains 536 rows, each representing a clone, and 8 columns, each representing a time point measured by month. By using only the first *j* = 8, 7, ...1 time points of data (leaving out 8 − *j* time points), seven additional simulation studies to find $L_{e}^{*}$ were performed. As shown in Fig. G1 in Appendix G of [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"}, reduction in the number of time samples flattens the MSE but preserves its minimum near $L_{e}^{*} \approx 23.4 - 23.6$ provided at least 2-3 samples are used. We have also excluded intermediate samples to mimic larger sampling gaps Δ*t*~*j*~ and found similar results.

Next, we examined the effects of sample thresholding on our parameter inference. By eliminating clones whose average abundances are under a certain threshold, we will observe fewer clones in the large-*z* bins depicted in [Fig 4](#pcbi.1006489.g004){ref-type="fig"}. Since larger clones with fewer absences contribute most to the MSE, our results will not be affected as long as the threshold is not too large. Provided we apply the same threshold to both the simulated and experimental data, there should not be systematic bias in our results. The MSEs generated using different thresholds are plotted in Fig. G2 in Appendix G of [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"} and show that the inferred value $L_{e}^{*} \approx 23.4$ remains essentially unchanged provided the threshold level is low enough to retain approximately at least 40% (about 200) of the clones (see Fig. G2(a-f) in Appendix G). With fewer clones retained (\< 200), the LSE of *L*~*e*~ shifts only modestly to $L_{e}^{*} \approx 24.3$. Thus, we conclude that our inference of *L*~e~ is robust to increases in sampling threshold as along as a reasonable number of clones (≳ 200) are counted.

Data analysis and fitting for animals 2RC003 and RQ3570 {#sec014}
-------------------------------------------------------

The data from the three different monkeys vary in their numbers of tagged clones transplanted and the lengths of the experiments. For animal RQ5427/2RC003/RQ3570, there are 536/1371/442 clones that are detected at least once within 67/103/38 months. The fraction of cells in all tracked clones in animal RQ5427/2RC003/RQ3570 was approximated by the average fraction of cells that were EGFP+ marked over time, around 0.052/0.049/0.086 (the ratios between green square and blue triangle markers in Figs [1(a)](#pcbi.1006489.g001){ref-type="fig"}, [10(a)](#pcbi.1006489.g010){ref-type="fig"} and [11(a)](#pcbi.1006489.g011){ref-type="fig"}), respectively. Figs [10](#pcbi.1006489.g010){ref-type="fig"} and [11](#pcbi.1006489.g011){ref-type="fig"} also show the clone abundances, the MSE functions, and the statistics of *Y*(*z*).

![(a-b) Experimental data for animal 2RC003. (c) Difference between experimental ${\hat{Y}}_{z}$ and simulated *Y*~z~(*L*~e~) as a function of *L*~e~. The values of *h*~*i*~s are set to be equal to $H^{+}{\hat{y}}_{i}$, and the model was simulated 200 times at each value of *L*~e~. Other parameters are taken from Tables [1](#pcbi.1006489.t001){ref-type="table"} and [2](#pcbi.1006489.t002){ref-type="table"}. The LSE $L_{e}^{*} = 25.0$ and $\left( A_{\text{ss}}^{+} \right)^{*} = 6.7$. (d) Comparison of the optimal *Y*~*z*~ to the experimental ${\hat{Y}}_{z}$.](pcbi.1006489.g010){#pcbi.1006489.g010}

![Experimental data (a-b) and fitting results (c-d) for animal RQ3570.\
The values of *h*~*i*~s are set to be equal to $H^{+}{\hat{y}}_{i}$. Other parameters are taken from Tables [1](#pcbi.1006489.t001){ref-type="table"} and [2](#pcbi.1006489.t002){ref-type="table"}. The LSE fitting results are $L_{e}^{*} = 24.0$ and $\left( A_{\text{ss}}^{+} \right)^{*} = 19.3$.](pcbi.1006489.g011){#pcbi.1006489.g011}

Despite differences among the animals and the large variability in the estimated values of *α* and *H*~ss~ individually reported in the literature \[[@pcbi.1006489.ref004], [@pcbi.1006489.ref011], [@pcbi.1006489.ref012]\], the estimates of $\left( A_{\text{ss}}^{+} \right)^{*}$ and $L_{e}^{*}$ are rather similar across the three animals. For animal 2RC003, the optimal estimates are $L_{e}^{*} \approx 25.0$, while for animal RQ3570, $L_{e}^{*} = 24.0$. The corresponding estimates for *A*\*, after considering the constraint [Eq (13)](#pcbi.1006489.e060){ref-type="disp-formula"} and the EGFP+ ratios in [Table 2](#pcbi.1006489.t002){ref-type="table"}, are 282.7, 136.7, and 224.4.

10.1371/journal.pcbi.1006489.t002

###### Summary of specific parameter values for monkeys 2RC003 and RQ3570 derived from experimental measurements \[[@pcbi.1006489.ref013]\] or obtained by calculations ($L_{e}^{*}$ and $\left( A_{\text{ss}}^{+} \right)^{*}$).

![](pcbi.1006489.t002){#pcbi.1006489.t002g}

  Parameter                                Reference range or LSE value                          
  ---------------------------------------- ------------------------------ ---------------------- ----------------------
  ${\hat{C}}_{s}$                          536                            442                    1371
  $\left( A_{\text{ss}}^{+} \right)^{*}$   14.7                           6.7                    19.3
  $A_{\text{ss}}^{*}$                      282.7                          136.7                  224.4
  $L_{e}^{*}$                              23.4                           25.0                   24.0
  *M*~ss~                                  3.2 × 10^9^                    4.6 × 10^9^            3.8 × 10^9^
  *S*^+^(*t*~*j*~)                         (5.0 − 30) × 10^3^             (2.1 − 8.6) × 10^3^    (7.0 − 10.8) × 10^3^
  EGFP+ ratio                              0.052                          0.049                  0.086
  *ε*(*t*~*j*~)                            (2.8 − 20) × 10^−5^            (1.2 − 4.2) × 10^−5^   (2.4 − 3.0) × 10^−5^
  Δ*t*~*j*~                                150 − 330                      180 − 660              150 − 260

We also compared how the simulated LSE $Y_{z}\left( L_{e}^{*} \right)$ fits the experimental ${\hat{Y}}_{z}$ for all three animals. Note that for each specific *z*, the value of *Y*~*z*~ is the conditional mean of the values of *y*~*i*~ for which each clone *i* exhibits exactly *z* absences. Even though for any specific *z*, the distribution of the corresponding *y*~*i*~s is unknown, their mean *Y*~*z*~ should follow a normal distribution according to the central limit theorem. We use a one-sample t-test to compare ${\hat{Y}}_{z}$ against the mean of the $Y_{z}\left( L_{e}^{*} \right)$ s generated from 10000 simulations using the optimal $L_{e} = L_{e}^{*}$. For animal RQ5427, we actually performed seven one-sample t-tests on the *Y*~*z*~ = {*Y*~1~, *Y*~2~, ..., *Y*~7~} to find the seven p-values {0.69, 0.53, 0.58, 0.17, 0.68, 0.01, 3 × 10^−5^}. Except for the last two p-values (corresponding to the bins *z* = 6 and *z* = 7), all other bins easily pass the one-sample t-test at a significance level of 0.05. Clones with *z* = 6, 7 are much smaller and more severely corrupted by noise, such as that induced during PCR amplification, and thus provide less reliable information.

Comparisons of the test results among the three animals, together with comparisons among Figs [7(b)](#pcbi.1006489.g007){ref-type="fig"}, [10(d)](#pcbi.1006489.g010){ref-type="fig"} and [11(d)](#pcbi.1006489.g011){ref-type="fig"}, show qualities of fit ordered according to RQ3570 \< RQ5427 \< 2RC003. This sequence of fitting qualities is consistent with the increasing experimental times RQ3570 \> RQ5427 \> 2RC003, suggesting that age-associated changes of stem cell clone sizes cannot be fully neglected (which we did by fixing {*h*~*i*~}) \[[@pcbi.1006489.ref048]\]. As is evident from [Fig 10(a)](#pcbi.1006489.g010){ref-type="fig"}, several clones start to dominate after month 64; this coarsening phenomenon is not evident in the data of the other two animals. Animal RQ3570 was sacrificed at month 38, so no obvious coarsening is observed and no clones strongly dominate (see [Fig 11](#pcbi.1006489.g011){ref-type="fig"}). A summary of the parameters and fitting results for all animals is given in [Table 2](#pcbi.1006489.t002){ref-type="table"}.

Discussion {#sec015}
==========

In this study, we analyzed a decade-long clonal tracking experiment in rhesus macaques and developed mechanistic and statistical models that helped us understand two salient features of clone abundance data: the heterogeneous (nonuniform) distribution of clone sizes and the temporal fluctuation of clone sizes. Below, we further discuss the implications of our results, the structure of our mechanistic model, and the potential effects of including additional biological processes.

Comparison to previous studies {#sec016}
------------------------------

The long-term clonal tracking data we analyzed were generated from a huge number of initially tagged HSPCs (*C*~h~(0) ∼ 10^6^ − 10^7^) \[[@pcbi.1006489.ref013]\], a large number of observed clones (*C*~s~ ∼ 10^2^ − 10^3^), small numbers of sequenced cells that carry tags (${\hat{S}}^{+}\left( t_{j} \right) \sim 10^{3} - 10^{4}$), and infrequent sampling (Δ*t*~*j*~ \> 5 months). These features present significant challenges to the modeling and analysis over previous studies that mostly focused on one or a few clones \[[@pcbi.1006489.ref005], [@pcbi.1006489.ref015], [@pcbi.1006489.ref017], [@pcbi.1006489.ref018]\].

In a previous analysis, Goyal et al. \[[@pcbi.1006489.ref004]\] aggregated the clone abundance data across *all* mature cell types and studied the distribution of the *number* of clones of specific size. At each time point, they ordered the clones according to their sizes. Thus, the ordering can change across samples as some clones expand while others diminish. They found that the cumulative clone-number distribution (defined as the number of clones of a specific size or less) of the size-ordered clones becomes stationary as soon as a few months after transplantation. They proposed a neutral birth-death description of progenitor cells and fitted the *expected* value of clone counts in each sample by assuming $h_{i} \equiv 1\forall i\left( {P\left( {h,t} \right) = 1\left( {h,1} \right)} \right)$ and tuning parameters in the downstream progenitor and mature-cell compartments. By focusing on aggregate clone counts, this study could not distinguish the dynamics of individual clones, nor could it predict the persistence of clone sizes over time. Since individual clone sizes (*h*~*i*~, *n*~*i*~, *m*~*i*~, *s*~*i*~ of the same tag *i*) were not tracked, mechanisms driving the dynamics, and in particular, the variability and fluctuations of *individual* clone sizes that drive disappearances and reappearances, remain unresolved \[[@pcbi.1006489.ref004]\].

In our model, heterogeneity of clone sizes is explicitly generated by stochastic HSC self-renewal of cells of each tag, and extinctions and resurrections arise from a generation-limited progenitor proliferation assumption. We infer model parameters as listed in [Table 2](#pcbi.1006489.t002){ref-type="table"}. Combining the results with previous experimental and theoretical estimates of *H*~ss~ ≈ 1.1 × 10^4^ − 2.2 × 10^4^ \[[@pcbi.1006489.ref004], [@pcbi.1006489.ref049]\] results in *α* = 0.0045 − 0.027, slightly larger than, but still consistent with, the estimates *α* = 0.0013 − 0.009 by Shepherd *et al*. \[[@pcbi.1006489.ref011]\]. Previous studies that modeled total peripheral blood population estimated *α* ≈ 0.022 and *H*~ss~ ≈ 1.1 × 10^6^/kg for dogs and *α* ≈ 0.044 and *H*~ss~ ≈ 1.1 × 10^6^/kg for humans \[[@pcbi.1006489.ref012]\]. These estimates yield a value of *αH*~ss~ about 10^2^ − 10^3^ times greater than ours, which is nonetheless consistent with our steady-state constraint [Eq (13)](#pcbi.1006489.e060){ref-type="disp-formula"} because they assumed a much smaller *L* ≈ 15 − 18 for dog and 16 − 21 for human. This difference in the estimates of *L* may be partially attributed to the transplant conditions under which the rhesus macaque experiments were performed \[[@pcbi.1006489.ref013]\]. Alternative model assumptions and differing values of other parameters may also contribute to this difference. For example, the extremely large value of *H*~ss~ ≈ 10^7^ used in \[[@pcbi.1006489.ref034]\] will naturally decrease their estimate for $L_{e}^{*}$ relative to that of our analysis.

Model structure, sensitivity to parameters, and cellular heterogeneity {#sec017}
----------------------------------------------------------------------

Uncertainties in values of parameters such as *μ*~h~, *p*~h~, *K*~h~, and other factors that tune the symmetric-asymmetric modes of HSC differentiation or involve HSC activation processes \[[@pcbi.1006489.ref050]\] will impart uncertainty in determining *P*(*h*) and {*h*~*i*~}. We have assumed *P*(*h*) satisfies a master equation and depends on only two effective parameters λ and *C*~h~. However, we have demonstrated that the statistical properties of *Y*~*z*~ are quite insensitive to the upstream configuration {*h*~*i*~} and hence to λ and *C*~h~ for a wide range of their values (see [Fig 8](#pcbi.1006489.g008){ref-type="fig"}). In other words, very little information in {*h*~*i*~} is retained in the sampled abundances $\hat{f}\left( t_{j} \right)$ after HSCs differentiate and trigger random bursty peripheral blood-cell population dynamics.

Another feature we have ignored in our neutral model is cellular heterogeneity such as tag-dependent differentiation, proliferation, and death rates. Cellular heterogeneity in HSC differentiation rates could be described by different *α*~*i*~ for each clone *i*, and the total differentiation rate would be $A_{\text{ss}}^{+} = \sum_{i = 1}^{C_{h}}\alpha_{i}h_{i}$. Differences in *α*~*i*~ can be subsumed into a modified configuration {*h*~*i*~} which, as we have seen, does not strongly influence our parameter estimation based on the *Y*~*z*~ statistics. Thus, given the available data and how information is lost along the stages of hematopoiesis and sampling, the present quasi-steady-state analyses cannot resolve heterogeneity across HSC clones.

We have not investigated how cellular heterogeneity in progenitor and mature cells would affect our results, but clone-dependences in their birth and death rates could affect sizes and durations of population bursts and quantitatively affect our analysis. However, unless the statistics of inter-burst times are highly variable across clones, we do not expect cellular heterogeneity to qualitatively affect our conclusions.

Changing downstream parameters such as *μ*~m~ or invoking alternative mechanisms of terminal differentiation (see Appendix B in [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"}) can affect the shape of clonal bursts. We show in Appendix D in [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"} that these effects can be subsumed into the effective maximum progenitor generation *L*~e~. We have performed additional simulations to confirm that changing *μ*~m~ = 2 will not influence the fitting of $A_{\text{ss}}^{+}$ but increases $L_{e}^{*}$ by one. In other words, inference of $\left( A_{\text{ss}}^{+} \right)^{*}$ is robust against many upstream and downstream parameters, indicating that the intrinsic clone size fluctuations observed in the experimental data strongly constrain the total rate of HSC differentiation. On the other hand, uncovering the actual maximal generation *L*\* from $L_{e}^{*}$ is possible only when uncertainties in these other parameters are resolved.

Clonal stability *vs* clonal succession {#sec018}
---------------------------------------

Our model reduction was based on the separation of timescales of the slow HSC dynamics and the fast clonal aging dynamics. Since HSC clone sizes vary extremely slowly for primates ($\sim \mathcal{O}\left( 10^{2} \right)$ months), we ignored the homeostatic births/deaths of HSCs when fitting the temporal clonal variations. This is partially justified by visual inspection of Figs [1(b)](#pcbi.1006489.g001){ref-type="fig"}, [10(b)](#pcbi.1006489.g010){ref-type="fig"} and [11(b)](#pcbi.1006489.g011){ref-type="fig"} that show no significant variations of large clones' abundances is observed before 60 months. Instead, the random intermittent HSC differentiation events induce relatively short ($\sim \mathcal{O}\left( 1 \right)$ months) bursts of granulopoietic progeny that contribute strongly to temporal fluctuations of clone sizes. Such behavior are consistent to the "clonal stability" hypothesis \[[@pcbi.1006489.ref051]--[@pcbi.1006489.ref053]\], which assumes that a fixed group of HSCs randomly contributes to an organism's blood production at all times.

The alternative hypothesis of "clonal succession" \[[@pcbi.1006489.ref016], [@pcbi.1006489.ref054], [@pcbi.1006489.ref055]\] assumes that different groups of HSCs are sequentially recruited to the blood production at different times. This hypothesis would be consistent with our model only under a different set of parameters where HSCs self-renew/die at a rate comparable to that of Δ*τ*~b~, the duration of a granulocyte burst. For example, murine HSC turnover rates *μ*~h~ are hypothesized to be 10-fold higher than those in primates while the clonal aging dynamics (and its timescale Δ*τ*~b~) are relatively conserved across species \[[@pcbi.1006489.ref056]\]. According to our result in Appendix C in [S1 Appendix](#pcbi.1006489.s001){ref-type="supplementary-material"}, such a 10-fold increase in HSC death rate would lead to a 10-fold increase in HSC clone extinction rate, bringing the lifespans of HSC clones closer to the (progenitor) clonal aging timescale Δ*τ*~b~. This interpretation is consistent with the fact that hematopoiesis in large primates has been described in terms of "clonal stability" while hematopoiesis in mice has been described in terms of "clonal succession" \[[@pcbi.1006489.ref016], [@pcbi.1006489.ref051]--[@pcbi.1006489.ref055]\]. We thus predict that with even longer tracking (\> 100 months), the "clonal succession" mechanism could be significant in primates also.

Summary and future directions {#sec019}
-----------------------------

In summary, we have built mechanistic and statistical models that enable the quantitative analysis of noisy and infrequent clonal tracking data. We focused on the huge temporal variability observed in the sampled clone abundances and defined a robust statistical measure *Y*~*z*~ of sample-to-sample clone size variability through the number of clonal disappearances. Of course, there is a nearly endless list of details such cellular heterogeneity and more complex biology that we did not include, but given the noisy data, we propose and quantify the simplest explanation for the observed heterogeneous clone abundances and the temporal "extinctions and resurrections". The key ingredients in our mechanistic model are HSC self-renewal (quantified by the effective parameter λ), intermittent HSC differentiation (quantified by the parameter $A_{\text{ss}}^{+}$), and an effective maximum progenitor generation (quantified by the effective parameter *L*~e~). Although we cannot fully resolve λ from data, the obvious mismatch between experiment and our model when λ is small shows that a certain level of HSC clone-size heterogeneity (larger λ ≈ 1) is necessary to match the sampled data. Similarly, we cannot fully resolve *α* and $H_{\text{ss}}^{+}$, but their product, the total tagged HSC differentiation rate $A_{\text{ss}}^{+} = \alpha H_{\text{ss}}^{+}$, is one of the key parameters constrained by our modeling. By minimizing an objective function of *Y*~*z*~ over effective model parameters, we found LSE values $L_{e}^{*} = 23 - 25$ and $\left( A_{\text{ss}}^{+} \right)^{*} = 100 - 300$ for the three rhesus macaques. These quantities could not be inferred from the total, more static cell populations. These results also imply that true dynamical changes in $A_{\text{ss}}^{+}$ and *L*~e~ could be masked by the intrinsically bursty dynamics of each clone but provide a framework for future study into extrinsic perturbations.

Our analysis provides insight into the variables and experimental conditions to which parameter inference is most sensitive, possibly guiding the design of future experiments. The approach and models can also be readily extended to quantify white blood cells of other types. For example, the mechanistic model can be directly applied to monocytes since they also have relatively simple dynamics and do not proliferate in the periphery \[[@pcbi.1006489.ref057]\]. Peripheral lymphocytes, however, would require additional experimental information because their populations are more sensitive to the state of the animal and can homeostatically proliferate \[[@pcbi.1006489.ref038]\].
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